Ph: 03 9328 4573

Level 1, Suite 123
Chelsea House
55 Flemington Road
North Melbourne VIC 3051

News


Parkville Allergy, Asthma and Immunology Consultants have moved across the road to new premises at Suite 123, 55 Flemington Rd. The practice is now named “
Melbourne Allergy, Asthma and Immunology Consultants”. This move will enable expansion of clinical services offered with recruitment of nurses and dieticians to the practice as well as recruiting further specialist associates to provide excellent specialist care to people with Allergic diseases and Asthma – and reduce the wait for appointments.

Visit the new MAAIC website:
www.allergyasthma.com.au

Parkville Allergy Asthma & Immunology Consultants

Parkville Allergy Asthma & Immunology Consultants is a Melbourne allergy clinic that offers specialist diagnosis and treatment of allergic disease, asthma and immune deficiencies.

Allergy Testing Melbourne


As well as offering allergy skin testing, we provide our expert opinion on conditions such as rhinitis, asthma, anaphylaxis, food allergy, hay fever, stinging insect allergy, urticaria and angioedema and immunodeficiency.

Allergy Specialist Melbourne


Clinic founder Prof Jo Douglass is the Head of the Department of Clinical Immunology and Allergy at the Royal Melbourne Hospital and is actively involved in ground breaking research together with colleagues from the Royal Melbourne Hospital, the University of Melbourne and the Walter and Eliza Hall Institute.
Level 1, Suite 123
Chelsea House
55 Flemington Road
North Melbourne VIC 3051
  • Melbourne Allergy Testing

    Caption Text

    Link
  • Allergy Specialist Melbourne

    Caption Text

    Link
  • Melbourne Allergy Testing

    Caption Text

    Link
  • Allergy Specialist Melbourne

    Caption Text

    Link
  • Melbourne Allergy Testing

    Caption Text

    Link
  •  What’s New?


    Allergen shortages

    Whilst there have been problems with allergen availability in Australia for immunotherapy, supply from several companies is now available and most patients have been contacted to make sure they can continue their immunotherapy if they wish.